Showing results (61-70 of 66) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.Journal of Medicinal Chemistry|May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolinesS M Bromidge, S Dabbs, D T Davies, et al.Bioorganic & Medicinal Chemistry Letters|June 25, 2005
Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonistsS Röver, D R Adams, A Bénardeau, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2005
Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonistsHans G F Richter, D R Adams, A Benardeau, et al.Journal of Medicinal Chemistry|March 29, 2000
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agentS M Bromidge, S Dabbs, D T Davies, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Indoline derivatives as 5-HT(2C) receptor agonistsJ M Bentley, D R Adams, D Bebbington, et al.Pageof 7